Doximity, Inc. DOCS
26.35
0.31
1.19%
as of 25 Sep
- Market cap
- $4.6B
- P/E
- 29.6×
Follow DOCS
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 17.21% | 19.28% | 23.82% | 24.61% |
+8 more TTM periods Free account |
|
| 14.60% | 16.42% | 20.56% | 21.30% | ||
ROIC |
53.13% | 66.42% | 61.12% | 71.03% | |
Return on Tangible Assets |
21.34% | 24.28% | 27.82% | 26.15% | |
Average Days of Receivables |
98.87 | 81.95 | 89.62 | 75.96 | |
Free Cash Flow per Share |
1.63 | 1.70 | 1.64 | 1.66 | |
Free Cash Flow |
297.03 | 317.56 | 307.27 | 312.11 | |
Capital Expenditures |
(9.32) | (8.90) | (8.15) | (7.61) | |
Piotroski F-Score |
4.00 | 4.00 | 5.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
19.10% | 19.21% | 18.40% | 16.20% | |
Accounts Receivable Turnover |
4.11 | 4.72 | 4.34 | 4.89 | |
Accounts Payable Turnover |
18.50 | 26.22 | 20.37 | 17.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
30.30 | 20.81 | 26.71 | 26.33 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.26) | (0.22) | (0.13) | (0.11) | |
Research and Development Expense of Revenue |
21.72% | 20.27% | 18.25% | 16.77% | |
Selling, General and Administrative Expense of Revenue |
36.75% | 35.50% | 34.06% | 33.71% | |
Share Based Compensation of Revenue |
20.82% | 18.86% | 16.14% | 14.29% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.83 | 1.67 | 1.32 | 1.26 | |
Depreciation/Fixed assets |
1.25 | 1.12 | 0.96 | 0.81 | |
Capex/Depreciation |
(0.39) | (0.44) | (0.50) | (0.60) | |
Revenue per Share |
3.59 | 3.45 | 3.40 | 3.31 | |
Operating CF per Share |
1.68 | 1.75 | 1.68 | 1.70 | |
Capex per Share |
(0.05) | (0.05) | (0.04) | (0.04) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
25.48% | 30.40% | 37.54% | 40.72% |
Columns are period end dates